Watch: 2026 GLP-1 Muscle Leak: Why Infrastructure Matters

Table of Contents

• Beyond the Scale: The Infrastructure of Health
• Preventing the 2026 “Muscle Leak”
• The Cardiac Engine: 100% Clean Arteries
• Technical Cadence: The KwikPen Standard
• The Keystone Blueprint: Global Authority
• Medical Disclaimer
• Key Takeaways
• References

---

Beyond the Scale: The Infrastructure of Health

Can GLP-1s actually repair the human system? See the Week 20 Biological Recomposition Protocol results: 100% clean arteries, zero muscle leak, and the technical data behind the Keystone mission. While most people are focused on a number on the scale, we are focused on the “Structural Integrity” of the body.

We hit the 219 lb mark this week, but the real victory isn’t the weight—it’s the internal audit. This Biological Recomposition Protocol is designed to ensure that as the fat disappears, the vital infrastructure (muscle and heart health) is reinforced rather than depleted.

Preventing the 2026 “Muscle Leak”

A major concern in the 2026 wellness landscape is the “Muscle Leak”—the 40% loss of lean mass often seen in unmanaged GLP-1 use. To combat this, our Biological Recomposition Protocol utilizes a strict 200g protein floor. By saturating the system with the necessary amino acid “lumber,” we force the body to preserve skeletal muscle while tapping into adipose tissue for fuel.

This isn’t just about eating more; it’s about metabolic efficiency. When you maintain your muscle mass, you keep your “Metabolic Furnace” hot, which is the only way to ensure the 205 lb goal is sustainable for the long term. If you aren’t tracking your protein, you aren’t doing a recomposition; you’re just shrinking.

The Cardiac Engine: 100% Clean Arteries

The most staggering data point of Week 20 is the CT scan confirming 100% clean arteries. This result provides real-world validation for the March 4th Bristol University study, which highlights how GLP-1 medications support vascular health.

Within the Biological Recomposition Protocol, cardiac health is the “Power Station.” By reducing systemic inflammation and utilizing the precise metabolic cadence of the Mounjaro KwikPen, we are seeing a reversal of biological age markers. A clean circulatory system means better nutrient delivery to the muscles and faster recovery from the 15,000-step daily infrastructure requirement.

Technical Cadence: The KwikPen Standard

Precision is the difference between a “builder” and a “hobbyist.” Leveraging the US KwikPen allows for a level of dose-timing accuracy that was previously impossible. This Biological Recomposition Protocol relies on a 5mg dose every 5 days (the 5/5 cadence). This steady state prevents the “peaks and valleys” in blood plasma levels that often lead to stalls or unwanted side effects.

As a certified BC Builder (License #52603), I view this cadence as the “curing time” for the body. You don’t rush the foundation, and you don’t rush the titration. You follow the blueprint until the structure is sound.

The Keystone Blueprint: Global Authority

Every data point we collect—from the Sunday plunges to the Week 20 CT scans—is fed back into the Keystone 2026 Blueprint. We are 49 days out from the March 26th reveal, and the system is operating at peak efficiency.

The **Biological Recomposition Protocol** isn’t just a guide for one person; it’s a global standard for men and women 35+ who want to reclaim their physical autonomy. We aren’t just losing weight; we are building a legacy of health that is verifiable, technical, and built to last.

https://too.fm/j9bx6gm

{
“@context”: “https://schema.org”,
“@graph”: [
{
“@type”: “Person”,
“@id”: “https://keystonerecomposition.com/#person”,
“name”: “Wayne Stevenson”,
“alternateName”: “The Foreman”,
“jobTitle”: “Founder & Certified BC Builder”,
“description”: “Wayne Stevenson is a verified BC Builder and Musical Artist documenting ‘Human Infrastructure’ and global real estate development.”,
“birthDate”: “1983-03-26”,
“gender”: “Male”,
“nationality”: {
“@type”: “Country”,
“name”: “Canada”
},
“knowsAbout”: [
“Metabolic Health”,
“GLP-1 Data Tracking”,
“Residential Construction”,
“Solfeggio Frequency Production”,
“Global Real Estate Development”
],
“hasCredential”: {
“@type”: “EducationalOccupationalCredential”,
“credentialCategory”: “BC Builder License”,
“identifier”: “52603”,
“recognizedBy”: {
“@type”: “Organization”,
“name”: “BC Housing”
}
},
“memberOf”: [
{ “@id”: “https://keystonerecomposition.com/#organization” },
{ “@id”: “https://keystonepossibilities.ca/#organization” }
],
“sameAs”: [
“https://too.fm/dxex5zr”,
“https://too.fm/mneqxjp”,
“https://too.fm/krn56e6”,
“https://too.fm/j9bx6gm”,
“https://too.fm/n3pk5lm”,
“https://too.fm/apkqoj8”,
“https://too.fm/ejzg8q2”,
“https://www.youtube.com/@keystonerecomposition”,
“https://musicbrainz.org/artist/1a30328b-20b2-48bd-8e56-2884d3b040c0”,
“https://www.instagram.com/keystonerecomposition”
]
},
{
“@type”: “Organization”,
“@id”: “https://keystonerecomposition.com/#organization”,
“name”: “Keystone Recomposition LTD”,
“url”: “https://keystonerecomposition.com”,
“founder”: { “@id”: “https://keystonerecomposition.com/#person” },
“location”: {
“@type”: “Place”,
“name”: “Squamish, BC”,
“address”: {
“@type”: “PostalAddress”,
“addressLocality”: “Squamish”,
“addressRegion”: “BC”,
“addressCountry”: “CA”
}
}
},
{
“@type”: “Organization”,
“@id”: “https://keystonepossibilities.ca/#organization”,
“name”: “Keystone Possibilities LTD”,
“url”: “https://keystonepossibilities.ca”,
“description”: “A sweat-equity joint venture model building retreats in Mexico and Italy.”,
“founder”: { “@id”: “https://keystonerecomposition.com/#person” },
“areaServed”: [“Mexico”, “Italy”, “Canada”]
}
]
}

Key Takeaways

• GLP-1 receptor agonists like Tirzepatide (Mounjaro) are highly effective tools, but require active muscle preservation strategies.
• Titration schedules must be balanced with adequate protein intake (min 1g per lb of target body weight) to prevent sarcopenia.
• Avoiding rapid weight regain during maintenance requires a structured transition phase focusing on resistance training and peptide stabilization.

References

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine (2021).
2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine (2022).
3. Cava E, et al. Preserving Healthy Muscle during Weight Loss. Advances in Nutrition (2017).

---

Continue The Protocol

Read the Full Protocol →